News
Press ReleaseRevive Therapeutics Provides Update on its Cannabis-based Pharmaceutical Initiatives
TORONTO, Dec. 19, 2019 - Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE: RVV), a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to provide an update on its...
Revive Therapeutics Announces New Leadership Appointment and Board Change
TORONTO, Dec. 18, 2019 - Revive Therapeutics Ltd. (“Revive" and the “Company") (CSE: RVV), a cannabis life sciences company focused on the research, development, and commercialization of novel cannabinoid-based products, is pleased to announce that all the resolutions...
Revive Therapeutics Announces Results for the Three Months Ended September 30, 2019
TORONTO, Nov. 27, 2019 - Revive Therapeutics Ltd. (“Revive” and the “Company”) (CSE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, today announced its results for the...